Property:Age groups specification
Appearance
This is a property of type Text.
M
Muecke et al. (2014): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology: follow-up analysis of the survival data 6 years after cessation of randomization +
Start of the original study (Muecke et al., 2010): mean (SD); range: 64.3 (10.1); 31–80 years +
N
Najafizade et al. (2013): Preventive effects of zinc sulfate on taste alterations in patients under irradiation for head and neck cancers: A randomized placebo-controlled trial +
Mean (SD): 59.2 (16.5) +
Nasser et al. (2017): Vitamin D ointment for prevention of radiation dermatitis in breast cancer patients +
Mean (SD): 63 (8), range: 37-74 +
Newling et al. (1995): Tryptophan metabolites, pyridoxine (vitamin B6) and their influence on the recurrence rate of superficial bladder cancer. Results of a prospective, randomised phase III study performed by the EORTC GU Group +
Age in years, median (range): 65 (31-85) +
Ng et al. (2019): Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial +
Intervention arm: median=54 (interquartile range: 47-65);
placebo arm: median: 56 (interquartile range: 50-64) +
Nguyen et al. (2012): Randomized, Double-Blind, Placebo-Controlled Trial of Polyphenon E in Prostate Cancer Patients before Prostatectomy: Evaluation of Potential Chemopreventive Activities +
Median Age (SD) per arm:
Polyphenon E arm: 63.4 (5.9) years, placebo arm: 61.3 (5.7) years +
Niravath et al. (2019): Randomized controlled trial of high‐dose versus standard‐dose vitamin D3 for prevention of aromatase inhibitor‐induced arthralgia +
Median (range): 64 (44-82) +
O
Okabayashi et al. (2020): L-Carnitine Improves Postoperative Liver Function in Hepatectomized Patients +
Age (mean ± SD): intervention arm 73 ± 9.8 years, control arm 73 ± 10.7 years +
Olsen et al. (2001): The effect of aloe vera gel/mild soap versus mild soap alone in preventing skin reactions in patients undergoing radiation therapy +
Mean age of the participants = 56 years (Range: 18-84)
Aloe arm: <45 years = 18%; 45-59 years = 55%; >60 years = 27%
Control arm: <45 years = 18%; 45-59 years = 32%; >60 years = 50% +
Ota et al. (2014): The effect of pyridoxine for prevention of hand-foot-syndrome in colorectal cancer patients with adjuvant chemotherapy using capecitabine: A randomized study +
Age in years, mean: 64 +
P
Pace et al. (2003): Neuroprotective Effect of Vitamin E Supplementation in Patient Treated With Cisplatin Chemotherapy +
Median: 57.5; range: 28-74 years +
Median: 58.25; range: 28-74 years +
Panahi et al. (2012): Effect of Ginger on Acute and Delayed Chemotherapy-Induced Nausea and Vomiting: A Pilot, Randomized, Open-Label Clinical Trial +
Age range = 35-74 years, mean(SD) = 51.83(9.18) years +
Paur et al. (2017): Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA +
Age in years, mean (range): 63.49 (48-75) +
Portenoy et al. (2012): Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial +
Mean (SD) age = 58 (12.2) years
Range = 20-93 years +
Puataweepong et. al (2009): The efficacy of oral Aloe vera juice for radiation induced mucositis in head and neck cancer patients: a double-blind placebo-controlled study +
Mean age (min-max) per year:
Aloe arm: 60 (38-91) years
Placebo arm: 54 (31-84) years +
Age in years, mean (SD): 38.28 (14.07)
Age in years, median (range): 38 (10-66) +
R
Raei et al. (2013): Effect of herbal therapy to intensity chemotherapy-induced nausea and vomiting in cancer patients +
Age: 50.3 ± 13.1 +
Rao et al. (2014): The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study +
Mean (SD, range) = 55.96 (12.25, 26-85) years +
Raoufinejad et al. (2019): Oral calcitriol in hematopoietic recovery and survival after autologous stem cell transplantation: a randomized clinical trial +
Intervention arm: mean (SD): 47.53 (13.49), range: 21-65
placebo arm: mean (SD): 46.93 (14.39), range: 18-68 +